Companies / Solid Biosciences Inc.
Solid Biosciences Inc.
Nasdaq: SLDBCIK 1707502CHARLESTOWN, MA
Financials · FY2022
Ownership
107.2M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 0.87% | 937,802 |
| Institutions | 88.56% | 94,954,311 |
| Public float | 10.57% | 11,333,125 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 15
View all →| Insider | % of shares | Shares |
|---|---|---|
Cumbo AlexanderCEOPresident and CEO · Director | 0.22% | 235,405 |
Smith Ian FDirector | 0.13% | 134,705 |
Ganot IlanDirector | 0.12% | 126,771 |
Howton David TChief Operating Officer | 0.10% | 105,077 |
Tan KevinCFO & Treasurer | 0.09% | 99,422 |
Brooks GabrielChief Medical Officer | 0.08% | 89,466 |
Hanrahan JessieChief Regulatory Officer | 0.07% | 74,318 |
Herzich PaulChief Technology Officer | 0.07% | 72,638 |
Edelman JosephDirector · 10% owner | — | — |
Kolchinsky Peter10% owner | — | — |
Institutional holders 132
View all →| Holder | Value | % of shares |
|---|---|---|
| $85.73M | 11.10% | |
| $69.27M | 6.47% | |
| $67.25M | 8.71% | |
| $44.62M | 7.38% | |
| $43.37M | 7.17% | |
| $41.71M | 3.89% | |
| $32.80M | 5.42% | |
| $28.88M | 3.74% | |
| $19.49M | 3.22% | |
| $15.02M | 2.48% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Cumbo Alexander CEO | Sell | Common Stock | $516.6K | -80K -22.85% | 270,931 0.25% of shares | medium |
| Feb 4, 2026 | Cumbo Alexander CEO | Sell | Common Stock | $315.1K | -49K -18.05% | 222,018 0.21% of shares | medium |
| Feb 2, 2026 | Howton David T Executive | Sell | Common Stock | $243.1K | -38K -24.44% | 116,753 0.11% of shares | medium |
| Feb 2, 2026 | Brooks Gabriel Executive | Sell | Common Stock | $182.4K | -28K -22.66% | 96,708 0.09% of shares | medium |
| Feb 2, 2026 | Tan Kevin Executive | Sell | Common Stock | $172.7K | -27K -19.76% | 108,984 0.10% of shares | medium |
| Feb 2, 2026 | Hanrahan Jessie Executive | Sell | Common Stock | $170.8K | -27K -24.30% | 82,675 0.08% of shares | medium |
| Feb 2, 2026 | Herzich Paul Executive | Sell | Common Stock | $169.0K | -26K -24.71% | 79,972 0.07% of shares | medium |
| Feb 4, 2026 | Howton David T Executive | Sell | Common Stock | $121.7K | -19K -16.18% | 97,859 0.09% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Adage Capital Management, L.P. | Passive13G/A | — |
| Vestal Point Capital, LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SLDB | Common Stock | 83422E204 |